The company recalled its Pipeline Flex embolization device, a permanent mesh stent, because of a risk of the wire and tubes on the device’s delivery system to fracture and break off when the stent is being placed, retrieved or moved inside the patient.
The Pipeline Flex embolization device is used to treat brain aneurysms that bulge or balloon out of the sides of a blood vessel.
Fractured pieces of the stent could be left inside a patient’s brain bloodstream. It’s also possible that attempts to retrieve fractured pieces could make a patient’s condition worse, and fragments could cause continued blockage of blood vessels, stroke or death, the FDA said.
Medtronic has received 59 reports of device malfunctions, 10 reports of serious injuries and two reports of death related to the recall.
Read the FDA’s full news release here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
